MCMC
Matrix Capital Management Company Portfolio holdings
AUM
$223M
This Quarter Return
+13.19%
1 Year Return
-12.57%
3 Year Return
+145.82%
5 Year Return
+136.54%
10 Year Return
+717.06%
AUM
$13.1B
AUM Growth
+$13.1B
(+22%)
Cap. Flow
+$4.26B
Cap. Flow
% of AUM
32.44%
Top 10 Holdings %
Top 10 Hldgs %
94.7%
Holding
25
New
2
Increased
9
Reduced
–
Closed
2
Top Buys
| 1 |
NVIDIA
NVDA
|
$2.96B |
| 2 |
Qualcomm
QCOM
|
$614M |
| 3 |
ASML
ASML
|
$563M |
| 4 |
ANSS
Ansys
ANSS
|
$57.5M |
| 5 |
Okta
OKTA
|
$53.8M |
Top Sells
| 1 |
Moderna
MRNA
|
$77.8M |
| 2 |
PTC
PTC
|
$56.1M |
Sector Composition
| 1 | Technology | 78.75% |
| 2 | Industrials | 10.65% |
| 3 | Consumer Discretionary | 6.92% |
| 4 | Healthcare | 2.55% |
| 5 | Communication Services | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$4.24T
| $3.28B | 25% | 26,585,120 +23,926,608 | +900% | +$2.96B |
|
|
2
Qualcomm
QCOM
$173B
| $1.99B | 15.16% | 10,000,000 +3,080,236 | +45% | +$614M |
|
3
TransDigm Group
TDG
$78.8B
| $1.4B | 10.65% | 1,094,900 | – | – |
|
|
ALTR
4
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $1.22B | 9.28% | 12,430,000 | – | – |
|
5
Marvell Technology
MRVL
$54.2B
| $1.05B | 8.01% | 15,055,500 | – | – |
|
|
6
ASML
ASML
$292B
| $948M | 7.22% | 927,200 +550,000 | +146% | +$563M |
|
7
Amazon
AMZN
$2.44T
| $909M | 6.92% | 4,703,000 +253,000 | +6% | +$48.9M |
|
8
GlobalFoundries
GFS
$18.5B
| $855M | 6.51% | 16,914,952 +135,143 | +0.8% | +$6.83M |
|
9
Synopsys
SNPS
$112B
| $427M | 3.25% | 717,735 | – | – |
|
10
Workday
WDAY
$61.6B
| $355M | 2.7% | 1,586,043 | – | – |
|
11
Veeva Systems
VEEV
$44B
| $137M | 1.04% | 748,821 +250,000 | +50% | +$45.8M |
|
|
ANSS
12
DELISTED
Ansys
ANSS
| $104M | 0.79% | 323,778 +178,778 | +123% | +$57.5M |
|
13
Alphabet (Google) Class A
GOOGL
$2.57T
| $91.1M | 0.69% | 500,000 | – | – |
|
14
Perimeter Solutions
PRM
$3.28B
| $58.4M | 0.44% | 7,462,500 | – | – |
|
15
Zentalis Pharmaceuticals
ZNTL
$122M
| $57.1M | 0.43% | 13,959,973 | – | – |
|
|
16
Okta
OKTA
$16.4B
| $53.8M | 0.41% | +575,000 | New | +$53.8M |
|
17
Aura Biosciences
AURA
$389M
| $52.3M | 0.4% | 6,922,870 | – | – |
|
18
Zscaler
ZS
$43.1B
| $50.2M | 0.38% | 261,405 +243,000 | +1,320% | +$46.7M |
|
19
Adaptive Biotechnologies
ADPT
$2.01B
| $41.9M | 0.32% | 11,572,590 | – | – |
|
|
ADAP
20
Adaptimmune Therapeutics
ADAP
$15.6M
| $38M | 0.29% | 38,974,185 | – | – |
|
21
BridgeBio Pharma
BBIO
$9.89B
| $6.08M | 0.05% | 240,000 +70,000 | +41% | +$1.77M |
|
22
Unity
U
$16.7B
| $4.07M | 0.03% | 250,000 | – | – |
|
23
Geron
GERN
$893M
| $2.42M | 0.02% | +571,500 | New | +$2.42M |
|
|
24
Moderna
MRNA
$9.37B
| – | – | -730,000 | Closed | -$77.8M |
|
|
25
PTC
PTC
$25.6B
| – | – | -296,793 | Closed | -$56.1M |
|